These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2533943)

  • 1. [Study on the uremic protein binding inhibitors as uremic toxin: toxic effect on erythroid colony formation, lymphocyte blast formation and renal function].
    Kawashima Y
    Nihon Jinzo Gakkai Shi; 1989 Nov; 31(11):1151-61. PubMed ID: 2533943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uricosuric agents in uremic sera. Identification of indoxyl sulfata and hippuric acid.
    Boumendil-Podevin EF; Podevin RA; Richet G
    J Clin Invest; 1975 Jun; 55(6):1142-52. PubMed ID: 1133164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A furan fatty acid and indoxyl sulfate are the putative inhibitors of thyroxine hepatocyte transport in uremia.
    Lim CF; Bernard BF; de Jong M; Docter R; Krenning EP; Hennemann G
    J Clin Endocrinol Metab; 1993 Feb; 76(2):318-24. PubMed ID: 8432774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressive effect of quinolinic acid and hippuric acid on bone marrow erythroid growth and lymphocyte blast formation in uremia.
    Kawashima Y; Sanaka T; Sugino N; Takahashi M; Mizoguchi H
    Adv Exp Med Biol; 1987; 223():69-72. PubMed ID: 2965848
    [No Abstract]   [Full Text] [Related]  

  • 5. Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis.
    Niwa T; Ise M
    J Lab Clin Med; 1994 Jul; 124(1):96-104. PubMed ID: 8035108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of quinolinic acid in the development of anemia in renal insufficiency.
    Pawlak D; Koda M; Pawlak S; Wolczynski S; Buczko W
    Am J Physiol Renal Physiol; 2003 Apr; 284(4):F693-700. PubMed ID: 12620922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indoxyl sulfate increases the gene expressions of TGF-beta 1, TIMP-1 and pro-alpha 1(I) collagen in uremic rat kidneys.
    Miyazaki T; Ise M; Seo H; Niwa T
    Kidney Int Suppl; 1997 Nov; 62():S15-22. PubMed ID: 9350672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluid secretion in isolated proximal straight renal tubules. Effect of human uremic serum.
    Grantham JJ; Irwin RL; Qualizza PB; Tucker DR; Whittier FC
    J Clin Invest; 1973 Oct; 52(10):2441-50. PubMed ID: 4738063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated free fosphenytoin concentrations in uremic sera: uremic toxins hippuric acid and indoxyl sulfate do not account for the impaired protein binding of fosphenytoin.
    Dasgupta A; Havlik D
    Ther Drug Monit; 1998 Dec; 20(6):658-62. PubMed ID: 9853983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of deoxycytidine on 2-chloro-deoxyadenosine-mediated growth inhibition of normal human erythroid and myeloid progenitor cells.
    Bilgeri R; Petzer AL; Zilian U; Geisen FH; Schirmer M; Haun M; Konwalinka G
    Exp Hematol; 1993 Mar; 21(3):432-7. PubMed ID: 8095026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of oral sorbent, AST-120, on serum concentration of indoxyl sulfate in uremic rats].
    Niwa T; Yazawa T; Maeda K; Ise M; Sugano M; Kodama T; Uehara Y
    Nihon Jinzo Gakkai Shi; 1990 Jun; 32(6):695-701. PubMed ID: 2120492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indoxyl sulfate induces complex redox alterations in mesangial cells.
    Gelasco AK; Raymond JR
    Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1551-8. PubMed ID: 16434574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretory activity and aryl acid content of serum, urine, and cerebrospinal fluid in normal and uremic man.
    Porter RD; Cathcart-Rake WF; Wan SH; Whittier FC; Grantham JJ
    J Lab Clin Med; 1975 May; 85(5):723-31. PubMed ID: 1168235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of uremic toxins on hepatic uptake and metabolism of erythromycin.
    Sun H; Huang Y; Frassetto L; Benet LZ
    Drug Metab Dispos; 2004 Nov; 32(11):1239-46. PubMed ID: 15286055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressed serum and urine levels of indoxyl sulfate by oral sorbent in experimental uremic rats.
    Niwa T; Miyazaki T; Hashimoto N; Hayashi H; Ise M; Uehara Y; Maeda K
    Am J Nephrol; 1992; 12(4):201-6. PubMed ID: 1481866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of indoxyl sulfate in the progression of chronic kidney disease and cardiovascular disease: experimental and clinical effects of oral sorbent AST-120.
    Niwa T
    Ther Apher Dial; 2011 Apr; 15(2):120-4. PubMed ID: 21426500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indoxyl sulfate and progression of renal failure: effects of a low-protein diet and oral sorbent on indoxyl sulfate production in uremic rats and undialyzed uremic patients.
    Niwa T; Tsukushi S; Ise M; Miyazaki T; Tsubakihara Y; Owada A; Shiigai T
    Miner Electrolyte Metab; 1997; 23(3-6):179-84. PubMed ID: 9387112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indoxyl sulfate inhibits proliferation of human proximal tubular cells via endoplasmic reticulum stress.
    Kawakami T; Inagi R; Wada T; Tanaka T; Fujita T; Nangaku M
    Am J Physiol Renal Physiol; 2010 Sep; 299(3):F568-76. PubMed ID: 20534867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation of indoxyl sulfate in OAT1/3-positive tubular cells in kidneys of patients with chronic renal failure.
    Taki K; Nakamura S; Miglinas M; Enomoto A; Niwa T
    J Ren Nutr; 2006 Jul; 16(3):199-203. PubMed ID: 16825019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.